Aug. 19, 2026 ~ On this episode of HealthWatch, Lloyd Jackson speaks with Dr. Rami Arabo, medical oncologist and hematologist at Trinity Health Oakland Hospital, about a promising new experimental treatment for advanced pancreatic cancer. The conversation explores recently published clinical trial data showing improved response and survival rates among late-stage patients, how the drug targets KRAS mutations that drive cancer growth, and what the breakthrough could mean for patients and families seeking new treatment options. Dr. Arabo also discusses expanded access opportunities, candidate eligibility, insurance considerations following FDA approval, and the importance of a multidisciplinary care team, including specialized hepatobiliary surgeons, in advancing pancreatic and other gastrointestinal cancer care.